USE OF ALLOKIN-ALPHA TO STIMULATE LEUCOPOIESIS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS B AND C
- Authors: MYAZIN R.G1
-
Affiliations:
- Volgograd State Medical University
- Issue: No 3 (2012)
- Pages: 72-75
- Section: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/275809
- ID: 275809
Cite item
Open Access
Access granted
Abstract
Objective: to determine the efficacy of allokin-alpha for the stimulation of leucopoiesis in the treatment of chronic hepatitis B (CHB) and C (CHC). Subjects and methods. Seventy-six CHB and CHC patients with leucopenia were treated. Half of the patients received therapy incorporating allokin-alpha; the other half had traditional therapy. Results. In the patients with chronic viral hepatitides on combination therapy including allokin-alpha, leucopenia and neutropenia were shown to significantly diminish and to elevate the levels of white blood cells and segmented neutrophils (p < 0.05). Conclusion. Allokin-alpha is able to stimulate leucopoiesis in patients with CHB and CHC, which allows leucopenia to be corrected.
Keywords
Full Text
References
- Ивашкин В.Т. Болезни печени и желчевыводящих путей. М.: М-Вести, 2005. - 536 с.
- Емельянов Д.Н., Свириденко О.Ю., Мязин Р.Г. Тактика противовирусного лечения острых и хронических вирусных гепатитов на современном этапе. Гепатология 2004; 4: 42-48.
- Chou R., Carson S., Chan B. Pegylated interferons for chronic hepatitis C virus infection: an indirect analysis of randomized trials. J. Viral. Hepat. 2008; 15: 551-570.
- Sulkowski M., Shiffman M., Afdhal N. et al. Treatment-related anemia but not epoetin use in associated with higher SVR rates among persons treated with peginterferon-ribavirin: results from the Ideal study. Hepatology 2008; 48: 1851.
- Черныш С.И. Аллокины, антивирусные и противоопухолевые препараты нового типа. В кн.:Человек и лекарство: Материалы XII нац. конгр. М., 2005: 723.
- Chernysh S.I., Kim S.I., Bekker G.P. et al. Antiviral and antitumor peptides from insects. Proceedings of National Academy of Science (USA) 2002; 9(20): 12628-12632.
- Мязин Р.Г., Хабибуллин Э.Р. Противовирусный препарат Аллокин-альфа как стимулятор лейкопоэза у больных хроническими вирусными гепатитами В и С. Рос. журн. гастроэнтерол., гепатол., колопроктол. 2009; 19(5) (приложение 34), тез. 370: 98.
- Ершов Ф.И., Мезенцева М.В., Беккер Г.П. Интерфероны и другие цитокины при терапии острого вирусного гепатита С Аллокином-альфа. Terra Medica Nova 2007; 1: 40-43.
- Меньшиков В.В. Лабораторные методы исследования в клинике: Справочник. М.: Медицина, 1987. - 368 с.
Supplementary files
